CHRONIC USE OF PROTON PUMP INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF IMMUNE CHECKPOINT INHIBITOR COLITIS IN RENAL CELL CARCINOMA

被引：0
|
作者：
Yin, Jianyi
Elias, Roy
Peng, Lan
Levonyak, Nicholas
Asokan, Annapoorani
Christie, Alana
Kubiliun, Nisa
Brugarolas, James
Hammers, Hans
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1248
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [31] Effects of Immune Checkpoint Inhibitors on Histopathology of Renal Cell Carcinoma
    Setoodeh, Sasan
    Przybycin, Christopher
    Elias, Roy
    Rini, Brian
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 971 - 972
  • [32] Effects of Immune Checkpoint Inhibitors on Histopathology of Renal Cell Carcinoma
    Setoodeh, Sasan
    Przybycin, Christopher
    Elias, Roy
    Rini, Brian
    Brugarolas, James
    Kapur, Payal
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 971 - 972
  • [33] Are immune checkpoint combination therapies for intermediate and poor risk renal cell carcinoma better than immune checkpoint inhibitors combined with kinase inhibitors?
    McDermott, David F.
    Atkins, Michael B.
    LANCET ONCOLOGY, 2021, 22 (05): : 593 - 594
  • [34] Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
    Lazarus, Benjamin
    Chen, Yuan
    Wilson, Francis P.
    Sang, Yingying
    Chang, Alex R.
    Coresh, Josef
    Grams, Morgan E.
    JAMA INTERNAL MEDICINE, 2016, 176 (02) : 238 - 246
  • [35] Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
    Ivanova, Elizaveta
    Asadullina, Dilara
    Gilyazova, Gulshat
    Rakhimov, Radmir
    Izmailov, Adel
    Pavlov, Valentin
    Khusnutdinova, Elza
    Gilyazova, Irina
    BIOMEDICINES, 2023, 11 (03)
  • [36] HYPERCAPNIC RESPIRATORY INSUFFICIENCY ASSOCIATED WITH DUAL IMMUNE CHECKPOINT INHIBITORS IN A PATIENT WITH RENAL CELL CARCINOMA
    Walder, Jeremy R.
    Faiz, Saadia A.
    Bashoura, Lara
    CHEST, 2023, 164 (04) : 5521A - 5521A
  • [37] Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
    Lasorsa, Francesco
    di Meo, Nicola Antonio
    Rutigliano, Monica
    Milella, Martina
    Ferro, Matteo
    Pandolfo, Savio Domenico
    Crocetto, Felice
    Tataru, Octavian Sabin
    Autorino, Riccardo
    Battaglia, Michele
    Ditonno, Pasquale
    Lucarelli, Giuseppe
    BIOMEDICINES, 2023, 11 (04)
  • [38] Increased Risk of Serious Infection with Proton Pump Inhibitor Use in Children
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2023, 123 (11) : 62 - 62
  • [39] Impact of Proton Pump Inhibitor Use on Faecal Microbiome in Patients with NSCLC Treated with Immune Checkpoint Inhibitor
    Huang, Y.
    Lee, J.
    Sim, C. K.
    Zhao, J. J.
    Sooi, K.
    Wong, A.
    Tay, S. H.
    Soon, Y. Y.
    Aminkeng, F.
    Goh, B. C.
    Tan, D. S.
    Soo, R. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S256 - S257
  • [40] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    DRUGS, 2018, 78 (14) : 1443 - 1457
12345